Tor Audun Klingen

473 total citations
21 papers, 353 citations indexed

About

Tor Audun Klingen is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Tor Audun Klingen has authored 21 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 7 papers in Pathology and Forensic Medicine and 5 papers in Oncology. Recurrent topics in Tor Audun Klingen's work include Breast Cancer Treatment Studies (8 papers), Breast Lesions and Carcinomas (7 papers) and Cancer Cells and Metastasis (3 papers). Tor Audun Klingen is often cited by papers focused on Breast Cancer Treatment Studies (8 papers), Breast Lesions and Carcinomas (7 papers) and Cancer Cells and Metastasis (3 papers). Tor Audun Klingen collaborates with scholars based in Norway, Germany and United Kingdom. Tor Audun Klingen's co-authors include Lars A. Akslen, Elisabeth Wik, Einar Vigeland, Per Skaane, Solveig Hofvind, Ying Chen, Ying Chen, Ying Chen, Ingunn M. Stefansson and Turid Aas and has published in prestigious journals such as PLoS ONE, Scientific Reports and Annals of the Rheumatic Diseases.

In The Last Decade

Tor Audun Klingen

18 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tor Audun Klingen Norway 11 197 134 95 81 66 21 353
Amna Sheri United Kingdom 9 200 1.0× 72 0.5× 66 0.7× 147 1.8× 19 0.3× 20 306
Valentina Magri Italy 11 207 1.1× 63 0.5× 53 0.6× 132 1.6× 20 0.3× 28 345
Antonia Márquez Spain 10 294 1.5× 99 0.7× 50 0.5× 134 1.7× 32 0.5× 15 444
Yanjun Hou United States 12 269 1.4× 67 0.5× 48 0.5× 123 1.5× 40 0.6× 29 442
Milim Kim South Korea 11 183 0.9× 48 0.4× 77 0.8× 125 1.5× 51 0.8× 26 386
Valerie Cui Yun Koh Singapore 14 172 0.9× 75 0.6× 162 1.7× 180 2.2× 45 0.7× 27 416
Lounes Djerroudi France 8 137 0.7× 45 0.3× 39 0.4× 103 1.3× 50 0.8× 22 287
M. Rudas Austria 9 156 0.8× 45 0.3× 169 1.8× 177 2.2× 43 0.7× 24 412
Takuho Okamura Japan 10 207 1.1× 70 0.5× 39 0.4× 96 1.2× 72 1.1× 30 331
Lauren Nye United States 9 270 1.4× 76 0.6× 42 0.4× 115 1.4× 46 0.7× 37 369

Countries citing papers authored by Tor Audun Klingen

Since Specialization
Citations

This map shows the geographic impact of Tor Audun Klingen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tor Audun Klingen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tor Audun Klingen more than expected).

Fields of papers citing papers by Tor Audun Klingen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tor Audun Klingen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tor Audun Klingen. The network helps show where Tor Audun Klingen may publish in the future.

Co-authorship network of co-authors of Tor Audun Klingen

This figure shows the co-authorship network connecting the top 25 collaborators of Tor Audun Klingen. A scholar is included among the top collaborators of Tor Audun Klingen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tor Audun Klingen. Tor Audun Klingen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klingen, Tor Audun, et al.. (2025). Prognostic value of immune biomarkers in melanoma loco-regional metastases. PLoS ONE. 20(1). e0315284–e0315284.
2.
Klingen, Tor Audun, et al.. (2025). Detection and agreement of blood- and lymph vessel invasion assessed by immunohistochemistry in matched TURBT and radical cystectomy specimens. Pathology - Research and Practice. 269. 155917–155917.
4.
Chen, Ying, et al.. (2023). CD47 and CD68 expression in breast cancer is associated with tumor‐infiltrating lymphocytes, blood vessel invasion, detection mode, and prognosis. The Journal of Pathology Clinical Research. 9(3). 151–164. 13 indexed citations
5.
Klingen, Tor Audun, et al.. (2021). Fibulin-2 expression associates with vascular invasion and patient survival in breast cancer. PLoS ONE. 16(4). e0249767–e0249767. 4 indexed citations
7.
Chen, Ying, et al.. (2021). Tumor‐associated lymphocytes and macrophages are related to stromal elastosis and vascular invasion in breast cancer. The Journal of Pathology Clinical Research. 7(5). 517–527. 10 indexed citations
8.
Krüger, Kristi, Elisabeth Wik, Hawa Nalwoga, et al.. (2017). Expression of Nestin associates with BRCA1 mutations, a basal-like phenotype and aggressive breast cancer. Scientific Reports. 7(1). 1089–1089. 22 indexed citations
9.
Klingen, Tor Audun, et al.. (2017). Tumor-associated macrophages are strongly related to vascular invasion, non-luminal subtypes, and interval breast cancer. Human Pathology. 69. 72–80. 54 indexed citations
10.
Wik, Elisabeth, et al.. (2017). Extra-nodal extension is a significant prognostic factor in lymph node positive breast cancer. PLoS ONE. 12(2). e0171853–e0171853. 23 indexed citations
11.
Wik, Elisabeth, et al.. (2016). Evaluation of Tumor Cell Proliferation by Ki-67 Expression and Mitotic Count in Lymph Node Metastases from Breast Cancer. PLoS ONE. 11(3). e0150979–e0150979. 8 indexed citations
12.
Klingen, Tor Audun, Ying Chen, Ingunn M. Stefansson, et al.. (2016). Tumour cell invasion into blood vessels is significantly related to breast cancer subtypes and decreased survival. Journal of Clinical Pathology. 70(4). 313–319. 16 indexed citations
13.
Klingen, Tor Audun, et al.. (2014). Sinonasal adenoid cystic carcinoma following formaldehyde exposure in the operating theatre. Journal of Occupational Medicine and Toxicology. 9(1). 43–43. 11 indexed citations
14.
Chen, Ying, Tor Audun Klingen, Elisabeth Wik, et al.. (2014). Breast cancer stromal elastosis is associated with mammography screening detection, low Ki67 expression and favourable prognosis in a population-based study. Diagnostic Pathology. 9(1). 230–230. 23 indexed citations
15.
Klingen, Tor Audun, et al.. (2013). Expression of thyroid transcription factor-1 is associated with a basal-like phenotype in breast carcinomas. Diagnostic Pathology. 8(1). 80–80. 21 indexed citations
16.
Schiøtz, Hjalmar A., et al.. (2012). Nevrom i klitoris etter omskjæring. Tidsskrift for Den norske legeforening. 132(6). 629–630. 2 indexed citations
17.
Klingen, Tor Audun, et al.. (2010). Thyroid transcription factor-1 positive primary breast cancer: a case report with review of the literature. Diagnostic Pathology. 5(1). 37–37. 21 indexed citations
18.
Klingen, Tor Audun, et al.. (2009). Secondary breast cancer: a 5‐year population‐based study with review of the literature. Apmis. 117(10). 762–767. 41 indexed citations
20.
Klingen, Tor Audun, et al.. (2006). Angiomyofibroblastoma and Aggressive Angiomyxoma. Journal of Pelvic Medicine and Surgery. 12(4). 225–228.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026